5-((5-methyl-3-thienyl)oxy)-2(1H)-pyrimidinone: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 124533 |
| CHEMBL ID | 1965344 |
| MeSH ID | M0132826 |
| Synonym |
|---|
| nsc-610743 |
| nsc610743 |
| 2(1h)-pyrimidinone, 5-[(5-methyl-3-thienyl)oxy]- |
| 2(1h)-pyrimidinone, {5-[(5-methyl-3-thienyl)oxy]-} |
| 5-((5-methyl-3-thienyl)oxy)-2-pyrimidinol |
| 5-[(5-methyl-3-thienyl)oxy]pyrimidin-2-ol |
| NCI60_004797 |
| mtop |
| AKOS000281975 |
| 5-(5-methylthiophen-3-yl)oxy-1h-pyrimidin-2-one |
| 96518-97-7 |
| 2(1h)-pyrimidinone, 5-((5-methyl-3-thienyl)oxy)- |
| 5-((5-methyl-3-thienyl)oxy)-2(1h)-pyrimidinone |
| CHEMBL1965344 |
| DTXSID40242301 |
| 5-((5-methylthiophen-3-yl)oxy)pyrimidin-2(1h)-one |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||